Tech Center 3700 • Art Units: 3792
This examiner grants 83% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17817370 | MULTI-LASER MEDICAL SYSTEM AND METHODS OF USE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18784370 | LEAD INTEGRITY AND CLOSED-LOOP ALGORITHM DIAGNOSTIC | Non-Final OA | Medtronic, Inc. |
| 17813281 | MEDICAL DEVICE WITH ANGLED HEADER AND DELIVERY SYSTEM | Non-Final OA | Medtronic, Inc. |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | Final Rejection | EMORY UNIVERSITY |
| 17875231 | SURGICAL DEVICE SYSTEM | Non-Final OA | ARTHREX, INC. |
| 18577336 | ISOLATED PRESSURE MONITORING FOR CRYOGENIC BALLOON CATHETER | Non-Final OA | Medtronic Ireland Manufacturing Unlimited Company |
| 18724239 | Vascular Implant | Non-Final OA | BARD PERIPHERAL VASCULAR, INC. |
| 18724270 | Vascular Implant | Non-Final OA | BARD PERIPHERAL VASCULAR, INC. |
| 18711528 | INTRAVASCULAR BLOOD PUMPS, MOTORS, AND FLUID CONTROL | Non-Final OA | Shifamed Holdings, LLC |
| 18772206 | APPARATUS AND METHOD FOR NON-INVASIVE FRACTIONAL TREATMENT OF SKIN TISSUE | Non-Final OA | POLLOGEN LTD. |
| 18723136 | AUTOMATED EXTERNAL DEFIBRILLATOR | Non-Final OA | CELLAED LIFE SAVER PTY. LTD. |
| 18679964 | OCULAR THERAPY MODES AND SYSTEMS | Non-Final OA | i-Lumen Scientific, Inc. |
| 18662858 | METHODS AND DEVICES FOR PHOTOBIOMODULATION | Final Rejection | JelikaLite LLC |
| 18593526 | METHODS AND COMPOSITIONS OF CRYOABLATION WITH DRUG DELIVERY | Non-Final OA | Theromics, Inc. |
| 18275453 | LINEAR CRYOCATHETER | Non-Final OA | ArtFix LTD |
| 18012759 | ABLATION PROBE HAVING SEPARABLE OUTER SLEEVE AND FREEZING FUNCTION AND METHOD | Non-Final OA | TIANJIN MEIDIAN MEDICAL TECHNOLOGY CO., LTD. |
| 17995840 | DEVICE FOR OCCLUSION OF A LEFT ATRIAL APPENDAGE OF A HEART | Final Rejection | AURIGEN MEDICAL LIMITED |
| 17840836 | APPARATUS FOR LASER ENDO-VASCULAR ABLATION | Non-Final OA | Foreveryoung Technology Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy